Denmark· DK-28106980123
Cellcristin
A vincristine product containing vincristinsulfat, registered in Denmark by Orifarm A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Vincristine is registered in 16 of 19 countries.
Countries holding a registration under ATC L01CA02 (vincristine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Vincristine · ATC L01CA02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- VINCRISTINSULFAT
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- L01CA02
- ATC class
- Vincristine
- Defined daily dose
- 0.36 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106980123
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
583 interactions on record for vincristine.
Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vincristine · interactions on record
583 records
- 63 severe
- 282 moderate
- 25 minor
- 213 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01CA02
Vincristine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8d90928b-aa88-47dd-af21-c3e47da3a9e9 GET /v1/drugs/8d90928b-aa88-47dd-af21-c3e47da3a9e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "1 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28106980123",
"substance": "VINCRISTINSULFAT",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "45149"
}See everything about vincristine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.